Evaluation of Microscopic Observation Drug Susceptibility (MODS) and the string test for rapid diagnosis of pulmonary tuberculosis in HIV/AIDS patients in Bolivia

BMC Infectious Diseases

Faustino Torrico⁷  Roxana Challapa³  Marco Solano⁷  Maya Vallejo¹  Magaly Espinoza¹  Rosario Castro⁷  Caryn Bern⁴  Monica Pajuelo⁸  Ruth Saravia³  Daniel Lozano⁷  Robert H. Gilman⁶  Melissa J. Reimer-McAtee²  Meredith H. Lora⁵ 

[1]La Escuela Técnica de Salud, Cochabamba, Bolivia

[2]Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA

[3]Colectivo de Estudios Aplicados y Desarrollo Salud y Medio Ambiente, Cochabamba, Bolivia

[4]University of California in San Francisco, San Francisco, USA

[5]Department of Medicine, University of California in San Francisco, 505 Parnassus Ave, Rm 987, San Francisco 94143-0119, CA, USA

[6]Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA

[7]Facultad de Medicina, Universidad Mayor de San Simón, Cochabamba, Bolivia

[8]Universidad Peruana Cayetano Heredia, Lima, Peru

关键词: String test;    Resource-scarce;    Bolivia;    MODS;    AIDS;    HIV;    Tuberculosis;   

Others  :  1229532
DOI  :  10.1186/s12879-015-0966-0

 received in 2015-02-03, accepted in 2015-05-28,  发布年份 2015

【 摘 要 】

Background

Tuberculosis (TB) is the most common opportunistic infection and the leading cause of death in HIV-positive people worldwide. Diagnosing TB is difficult, and is more challenging in resource-scarce settings where culture-based diagnostic methods rely on poorly sensitive smear microscopy by Ziehl-Neelsen stain (ZN).

Methods

We performed a cross-sectional study examining the diagnostic utility of Microscopic Observation Drug Susceptibility liquid culture (MODS) versus traditional Ziehl-Neelsen staining (ZN) and Lowenstein Jensen culture (LJ) of pulmonary tuberculosis (TB) and multidrug-resistant tuberculosis (MDRTB) in HIV-infected patients in Bolivia. For sputum scarce individuals we assessed the value of the string test and induced sputum for TB diagnosis. The presence of Mycobacterium tuberculosis (Mtb) in the sputum of 107 HIV-positive patients was evaluated by ZN, LJ, and MODS. Gastric secretion samples obtained by the string test were evaluated by MODS in 102 patients.

Results

The TB-HIV co-infection rate of HIV patients with respiratory symptoms by sputum sample was 45 % (48/107); 46/48 (96 %) were positive by MODS, 38/48 (79 %) by LJ, and 30/48 (63 %) by ZN. The rate of MDRTB was 9 % (4/48). Median time to positive culture was 10 days by MODS versus 34 days by LJ (p < 0.0001). In smear-negative patients, MODS detected TB in 17/18 patients, compared to 11/18 by LJ (94.4 % vs 61.0 %, p = 0.03 %). In patients unable to produce a sputum sample without induction, the string test cultured by MODS yielded Mtb in of 9/11 (82 %) TB positive patients compared to 11/11 (100 %) with induced sputum. Of the 10 patients unable to produce a sputum sample, 4 were TB-positive by string test.

Conclusion

MODS was faster and had a higher Mtb detection yield compared to LJ, with a greater difference in yield between the two in smear-negative patients. The string test is a valuable diagnostic technique for HIV sputum-scarce or sputum-absent patients, and should be considered as an alternative test to induced sputum to obtain sample for Mtb in resource-limited settings. Nine percent of our TB+ patients had MDRTB, which reinforces the need for rapid detection with direct drug susceptibility testing in HIV patients in Bolivia.

【 授权许可】

   
2015 Lora et al.

【 图 表 】

Fig. 1.

Fig. 2.

【 参考文献 】

• [1]World Health Organization: Global tuberculosis report. Geneva; 2014. http://www.who.int/tb/publications/global_report/en/. Accessed 31 May 2015.
• [2]Ministerio de Salud y Deportes: Programa Nacional de Control de Tuberculosis. Boletín Informativo, Bolivia. 2012. http://snis.minsalud.gob.bo/tuberculosis/Docs/Boletin/Boletin%20TB%202012%20I.pdf. Accessed 31 May 2015.
• [3]Diagnostic standards and classification of tuberculosis in adults and children. Consensus from an expert panel. Am J Respir CritCare Med. 2000; 161:1376.
• [4]Lee MP, Chan JW, Ng KK, Li PC. Clinical manifestations of tuberculosis in HIV-infected patients. Respirology. 2000; 5:423-426.
• [5]Toossi Z, Mayanja-Kizza H, Hirsch CS, Edmonds KL, Spahlinger T, Hom DL, et al. Impact of tuberculosis on HIV-1 activity in dually infected. Clin Exp Immunol. 2001;2:233–8.
• [6]Badri M, Ehrlich R, Wood R, Pulerwitz T, Maartens G. Association between tuberculosis and HIV disease progression in a high tuberculosis prevalence area. Int. J. Tuberc. Lung Dis. 2001; 5:225-232.
• [7]Bakari M, Arbeit RD, Mtei L, Lyimo J, Waddell R, Matee M, et al. Basis for treatment of tuberculosis among HIV-infected patients in Tanzania: the role of chest x-ray and sputum culture. BMC Infect Dis. 2008;8:32.
• [8]Kwan C, Ernst J. HIV and Tuberculosis: a deadly human syndemic. Clin Microbiol Rev. 2011; 24(2):351-376.
• [9]Onubogu C, Nwokoye N, Kunle-Ope C, Yekeen R, Thecla I, Nwanneka T, et al. Sensitivity of direct smear microscopy for the diagnosis of TB in high HIV prevalent population. Scientific Research and Essays. 2012;7(5):593–7.
• [10]Elliott AM, Halwiindi B, Hayes RJ, Luo N, Tembo G, Machiels L, et al. The impact of human immunodeficiency virus on presentation and diagnosis of tuberculosis in a cohort study in Zambia. J Trop Med Hyg. 1993;96:1–11.
• [11]King L, Ahuja S. TB and HIV: Current Trends, Diagnosis, and Treatment. The Physicians’ Research Network. 2006; 11(2):17-23.
• [12]Chaudhary M, Gupta S, Khare S, Lal S. Diagnosis of tuberculosis in an era of HIV pandemic: a review of current status and future prospects. Indian J Med Microbiol. 2010; 28(4):281-289.
• [13]Roadmap for rolling out Xpert MTB/RIF for rapid diagnosis of TB and MDR-TB. 2010.
• [14]Theron G, Peter JG, van Zyl-Smit R, Mishra H, Streicher E, Murray S, et al. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am J Respir Crit Care Med. 2011;184(1):132–40.
• [15]Wikman-Jorgensen P, Llenas-Garcia J, Hobbins M, Ehmer J, Abellana R, Goncalves AQ, et al. Microscopic observation drug susceptibility assay for the diagnosis of TB and MDR-TB in HIV-infected patients: a systematic review and meta-analysis. Eur Respir J. 2014;44(4):973–84.
• [16]Pantoja A, Fitzpatrick C, Vassal A, Weyer K, Floyd K. Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis. Eur Respir J. 2013; 42(2):708-20.
• [17]Calvimontes Camargo JC, Maturano Trigo M, Colque R, Rocabado R, Valencia Rivero C. Estado Plurinacional de Bolivia Ministerio de Salud: Bolivia: Informe nacional de progreso en la respuesta al VIH/SIDA,2014. 2014.
• [18]Caviedes L, Lee T-S, Gilman RH, Sheen P, Spellman E, Lee EH, et al. Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. J Clinical Microbiol. 2000;38:1203–8.
• [19]Moore D, Evans CAW, Gilman RH, Caviedes L, Coronel J, Vivar A, et al. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med. 2006;355(15):1539–50.
• [20]Kent PT, Kubica GP. US Department of Health and Human Services: Public Health Mycobacteriology: A Guide for the Level III Laboratory. CDC, Atlanta; 1985.
• [21]Comina G, Mendoza D, Velazco A, Coronel J, Sheen P, Gilman RH, et al. Development of an automated MODS plate reader to detect early growth of Mycobacterium tuberculosis. J Microscopy. 2011;242(3):325–30.
• [22]Zimic M, Velasco A, Comina G, Coronel J, Fuentes P, Luna CG, et al. Development of a low-cost inverted microscope to detect early growth of Mycobacterium tuberculosis in MODS culture. PLoS One. 2010;5(3), e9577.
• [23]World Health Organization: Noncommercial culture and drug-susceptibility testing methods for screening patients for multi drug resistant tuberculosis: Policy statement. Geneva; 2011. http://whqlibdoc.who.int/publications/2011/9789241501620_eng.pdf. Accessed 31 May 2015.
• [24]Vargas D, Garcia L, Gilman RH, Evans C, Ticona E, Navincopa M, et al. Diagnosis of sputum-scarce HIV-associated pulmonary tuberculosis in Lima, Peru. The Lancet. 2005;365:150–2.
• [25]Beal CB, Viens P, Grant RG, Hughes JM. A new technique for sampling duodenal contents: demonstration of upper small-bowel pathogens. Am J Trop Med Hyg. 1970; 19(2):349-352.
• [26]Gilman RH, Islam S, Rabbani B, Ghosh H. Identification of gallbladder typhoid carriers by a string device. Lancet. 1979; 1:795-796.
• [27]Bae W, Salas A, Brady M, Coronel J, Colombo CG, Castro B, et al. Reducing the string test intra-gastric downtime for detection of Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 2008;12(12):1436–40.
• [28]De Cock KM, Wilkinson D. Tuberculosis control in resource poor countries: alternative approaches in the era of HIV. Lancet. 1995; 346:675-677.
• [29]Kawai V, Soto G, Gilman RH, Bautista CT, Caviedes L, Huaroto L, et al. Tuberculosis mortality, drug resistance, and infectiousness in patients with and without HIV infection in Peru. Am J Trop Med Hyg. 2006;75(6):1027–33.
• [30]Nicol MP, Zar HJ. New specimens and laboratory diagnostics for childhood pulmonary TB: progress and prospects. Paediatr Respir Rev. 2011; 12(1):16-21.
• [31]Hatherill M, Hawkridge T, Zar HJ, Whitelaw A, Tameris M, Workman L, et al. Induced sputum or gastric lavage for community-based diagnosis of childhood pulmonary tuberculosis? Arch Dis Child. 2009;94(3):195–201.
• [32]Morse M, Kessler J, Albrecht S, Kim R, Thakur R, Nthobatsang R, et al. Induced sputum improves the diagnosis of pulmonary tuberculosis in hospitalized patients in Gaborone, Botswana. Int J Tuberc Lung Dis. 2008;12:1279–85.
• [33]Parry CM, Kamoto O, Harries AD, Wirima JJ, Nyirenda CM, Nyangulu DS, Hart CA. The use of sputum induction for establishing a diagnosis in patients with suspected pulmonary tuberculosis in Malawi. Tuber Lung Dis. 1995; 76:72-6.
• [34]Gonzales-Angulo Y, Wiysonge CS, Geldenhuys H, Hanekom W, Mahomed H, Hussey G, et al. Sputum induction for the diagnosis of pulmonary tuberculosis: a systematic review and meta-analysis. Eur J Clin Microbiol Infect Dis. 2012;31(7):1619–30.
• [35]Peter JG, Theron G, Pooran A, Thomas J, Pascoe M, Dheda K. Comparison of two methods for acquisition of sputum samples for diagnosis of suspected tuberculosis in smear-negative or sputum –scarce people: a randomized controlled trial. Lancet Respir Med. 2013; 1(6):471-8.